Rossari Biotech Q1 FY23 revenue up 88%; Profit up 17%
Profit after Tax (PAT) was up 18% for Q1 FY23 to reach Rs. 28.7 crore whereas EBITDA was up 52% to reach Rs. 57.7 crore
Profit after Tax (PAT) was up 18% for Q1 FY23 to reach Rs. 28.7 crore whereas EBITDA was up 52% to reach Rs. 57.7 crore
The strong topline performance was driven by incremental benefits accruing from the expanded capacity and was supported by continued positive demand across key products
The company is planning a Capex outflow of Rs. 70 crore for FY23 which will target further increase Sandila plant capacity by 4,000 MT
Baroda plant to be commissioned by June 2023, Mahad plant by H1 2023, and Bareilly plant by October 2022
Both the plants have a total Capex of Rs. 75 crore and expected production timeline is Q3 FY23
The brownfield expansion to introduce a new speciality chemical to aid Barium portfolio diversification is on track and is expected to be commissioned by H1 FY24
Company’s consolidated net sales totaled ¥252.3 billion (US$1.9 billion), up ¥51.1 billion, or 25.4%, compared with consolidated net sales in the first quarter of fiscal 2022
Company generated net sales of $2.5 billion in the second quarter, a 2 percent decrease from the prior quarter and a 13 percent increase over the same quarter of 2021
The acquisition will expand Hallstar’s manufacturing capacity and product portfolio, and will include the ester manufacturing plant, select product lines and site personnel
In the long term, once proposed expansions come on-stream, specialty vehicles would contribute a larger share of both revenues and profitability
Due to several rounds of price increases, the value growth in each category of decorative paints is higher than volume growth
The production is anticipated to be on-stream in the second half of 2022 and will ensure a global supply of HEP and NOP
First half 2022 net sales rose 11% versus prior year with gains in both segments
Prepared annually by ACC’s Economics and Statistics Department, the Guide to the Business of Chemistry divides the U.S. chemical industry into more than 30 categories of production, ranging from inorganic chemicals to plastic resins, adhesives and sealants to oilfield chemicals, and fertilizers to consumer products.
Company will invest approximately ¥16 billion to increase production capacity by approximately 70% to ensure a stable supply
Company's total income grew 10 per cent to Rs 409.58 Crores in the first quarter of this fiscal from Rs 371.54 crore in the corresponding period of FY'22
The report outlines how Orion is transforming its product portfolio to reflect sustainability in its business strategy
Driven by improved ease of doing business, strong infrastructural capabilities, services and entrepreneurial spirit, Industry’s growth story is very robust and sustainable. Industry requires both short and mid-term tactical strategy and a long term plan.
The company has reported total income of Rs. 93.41 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 0.26 crores during the period ended June 30, 2022.
Subscribe To Our Newsletter & Stay Updated